# Tolerance of Anti-Cancer Therapy in the Elderly

> **NCT05251922** · — · UNKNOWN · sponsor: **The Leeds Teaching Hospitals NHS Trust** · enrollment: 500 (estimated)

## Conditions studied

- Frailty
- Chemotherapeutic Toxicity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05251922
- **Lead sponsor:** The Leeds Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05251922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05251922, "Tolerance of Anti-Cancer Therapy in the Elderly". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05251922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*